Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
adjournment, affirmative, afforded, American, ASCO, Codification, Codificationand, Concurrent, disinterested, enterprise, entity, exceeded, exempt, extinguished, extinguishment, freestanding, guidance, holder, instrument, intent, mezzanine, nongovernmental, ofFASB, Ordinarily, par, pro, promissory, promulgated, rata, ratio, recovery, redeemable, resume, revaluation, revalued, Society, stakeholder, statute, supersede, volume, wholly
Removed:
accounted, agency, aggregating, Alzheimer, annum, APB, apparent, assumption, BACE, bulletin, carrying, compound, contingent, deducting, discussed, earn, fully, GECC, inflammatory, IRB, main, monthly, Moving, network, Opinion, periodically, progression, regulating, repurchase, tier, tightening, type, unregistered, utilizing, vacated, viral
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.62 Sunesis Pharmaceuticals, Inc. Change of Control Payment Plan
- 10.63 Sunesis Pharmaceuticals, Inc. 2009 Bonus Program
- 10.65 Medical Benefits Arrangement with James W. Young, PH.D.
- 31.1 Certification of CEO As Required by Rule 13A-14(A)
- 31.2 Certification of CFO As Required by Rule 13A-14(A)
- 32.1 Certification of CEO As Required by Rule 13A-14(B)
- 32.2 Certification of CFO As Required by Rule 13A-14(B)
VIRX similar filings
Filing view
External links
Exhibit 10.65
Medical benefits arrangement with James W. Young, Ph.D.
In connection with the 2009 restructuring, James W. Young, Ph.D. retired as Executive Chairman, effective as of April 3, 2009. In connection with his resignation as Executive Chairman, the Company agreed to cover Dr. Young’s medical benefits for a period of twelve months.